C'BON COSMETICS Co., Ltd.

C'BON COSMETICS Co., Ltd.

TTSE:4926
1,250.00
JPY
+6.00
(+0.48%)
5.22BMarket Cap
Nov 05Next Earn
C'BON COSMETICS Co., Ltd.
TSE:4926
(Tokyo Stock Exchange)

Recent

price

1,250.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
3,450.31
3,353.44
3,455.83
3,695.36
3,479.42
3,172.99
3,057.41
3,068.17
3,036.11
2,593.92
2,126.29
2,138.37
1,991.66
1,985.49
2,064.92
2,173.96
- -
Revenue per Share
159.08
61.14
120.46
206.73
75.51
25.83
43.14
93.93
33.81
-250.02
-145.27
10.48
-98.53
-6.16
31.84
50.11
- -
Basic EPS, GAAP
213.19
55.25
109.74
28.51
128.44
17.74
113.82
175.1
16.45
-48.99
-193.86
75.07
-131.34
-71.27
-217.48
129.75
- -
Free Cash Flow per Basic Share
80.55
84.74
93.12
83.44
85.18
73.87
41.76
41.98
41.32
39.71
0.21
0.19
19.97
5.16
20.05
20.13
- -
Dividend per Share
2,059.96
2,037.45
2,097.13
2,217.27
2,211.71
2,166.57
2,168.05
2,249.84
2,217.91
1,912.91
1,774.63
1,448.54
1,333.98
1,322.24
1,332.34
1,367.18
1,367.18
Book Value per Share
2,036.39
2,008.89
2,066.74
2,185.89
2,183.47
2,138.7
2,155.74
2,240.16
2,182.64
1,888.68
1,750.8
1,431.01
1,321.18
1,310.6
1,324.14
1,361.35
1,361.35
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
14,639
14,228
14,148
15,018
13,935
12,833
12,493
12,565
12,541
11,102
9,102
9,153
8,525
8,499
8,839
9,267
- -
Sales/Revenue/Turnover
14.93
15.53
16.92
19.41
15.29
14.18
2.6
4.55
2.01
-2.87
-9.93
2.12
-1.7
0.35
1.93
2.73
- -
Operating Margin (%)
322
294
297
292
374
359
314
316
297
303
224
224
272
142
153
216
- -
Depreciation Expense
675
259
493
840
302
104
176
385
140
-1,070
-622
45
-422
-26
136
214
- -
Net Income, GAAP
44.89
57
44.04
41.77
48.48
59.44
30.64
39.37
52.82
- -
- -
57.23
- -
202.06
2.07
10.36
- -
Effective Tax Rate (%)
4.61
1.82
3.49
5.59
2.17
0.81
1.41
3.06
1.11
-9.64
-6.83
0.49
-4.95
-0.31
1.54
2.31
- -
Profit Margin (%)
3,692
3,546
3,706
3,327
3,301
3,320
3,439
3,584
3,853
3,465
2,960
2,009
3,308
2,821
2,123
2,232
2,232
Working Capital
- -
- -
244
150
52
2
3
2
1
25
18
13
4
- -
- -
- -
- -
LT Debt
8,740
8,645
8,581
8,829
8,904
8,803
8,874
9,221
9,486
8,189
7,597
6,201
5,710
5,660
5,703
5,688
5,688
Total Equity
8.22
6.62
5.42
8.61
2.99
1.05
2.51
3.76
1.25
- -
- -
1.18
- -
-0.52
2.91
3.94
- -
Return on Invested Capital (%)
7.83
2.98
5.66
9.44
3.37
1.18
1.99
4.25
1.49
- -
- -
0.65
- -
-0.47
2.4
3.75
- -
Return on Capital (%)
7.87
2.98
5.73
9.65
3.41
1.18
1.99
4.25
1.49
-12.11
-7.88
0.65
-7.08
-0.46
2.4
3.75
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
4,824
5,162
5,221

Working Capital

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
Total Current Assets
- -
4,751
4,803
Cash, Cash Equivalents & STI
- -
2,742
3,016
Accounts Receivable, Net
- -
923
807
Inventories
- -
910
798
Total Current Liabilities
- -
2,546
2,571
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4%
-5.33%
-0.26%
Free Cash Flow
-1.46%
-82.74%
-159.41%
Net Income, GAAP
-258.62%
-360.27%
56.76%
Sales/Revenue/Turnover
-2.95%
0.45%
4.84%
Total Cash Common Dividend
1,039.93%
2,108.41%
0.01%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,105
2,282
2,047
2,065
8,499
2025
- -
- -
- -
- -
8,839
2026
- -
- -
- -
- -
9,267

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-4.39
20.68
-13.13
-9.31
-6.16
2025
- -
- -
- -
- -
31.84
2026
- -
- -
- -
- -
50.11

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5.16
2025
- -
- -
- -
- -
20.05
2026
- -
- -
- -
- -
20.13
Business
C'BON COSMETICS Co., Ltd. manufactures and sells cosmetics and quasi-drugs, including skincare, makeup, and body care products; skincare offerings encompass basic daily items such as facial cleansers, lotions, serums, creams, and masks, alongside specialized anti-aging and stress-relief formulations like the top-ranked FACIALIST TREATMENT MASSER cleansing cream and new Calla flower extract-infused anti-stress products; makeup products cover lip, eye shadow, cheek, nail, and foundation lines; body care includes shampoos, conditioners, and the Belleer hair care brand; beauty appliances and salon treatment services complement the portfolio through a network of 97 facialist salons providing skin counseling and oriental-style treatments. Founded in 1966 and headquartered in Tokyo with main operations in Kawasaki, Kanagawa, the company conducts research, development, manufacturing, and sales in-house, primarily targeting women seeking home care plus salon care programs in Japan, with select product distribution in China, Taiwan, Vietnam, Thailand, Russia, and Nigeria. Recent developments include the November 2025 discovery of oxytocin and cortisol effects on dermal hyaluronic acid, advancing stress-related skincare research; the January 1, 2026 relaunch of the core FACIALIST series with three refreshed products emphasizing skin foundational strength, hydration technology, and a five-step routine; the November 1, 2025 introduction of the Shikon Kenbi-Zakuro colored healthy beauty line leveraging fruit and fermentation benefits; and ongoing participation in the Cosme Bank Project for single-mother support via product donations, alongside direct salon growth with increased new customers and higher purchase values driving 6.9% revenue rise in fiscal 2025 interim results.